Article Details

US FDA allows Lilly's COVID-19 drug to be taken without remdesivir

Retrieved on: 2021-07-29 14:48:45

Tags for this article:

Click the tags to see associated articles and topics

US FDA allows Lilly's COVID-19 drug to be taken without remdesivir. View article details on hiswai:

Excerpt

In November, the U.S. Food and Drug Administration (FDA) approved Lilly and Incyte's (INCY.O) arthritis drug, baricitinib, in combination with remdesivir, ...

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up